SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-027406
Filing Date
2023-08-04
Accepted
2023-08-04 07:32:00
Documents
14
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K twist-20230803.htm   iXBRL 8-K 31837
2 EX-99.1 twst-20230630xex991.htm EX-99.1 121311
6 image_2.jpg GRAPHIC 23636
  Complete submission text file 0001628280-23-027406.txt   325240

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT twist-20230803.xsd EX-101.SCH 1944
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT twist-20230803_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT twist-20230803_pre.xml EX-101.PRE 12539
8 EXTRACTED XBRL INSTANCE DOCUMENT twist-20230803_htm.xml XML 2811
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

IRS No.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 231142166
SIC: 2836 Biological Products, (No Diagnostic Substances)